Shannon Bennett
Well-known member
[h=1]Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study[/h]
[h=4]Findings[/h] Between Dec 1, 2012, and Dec 1, 2013, we obtained individual serum samples from 10 009 individuals. Anti-MERS-CoV antibodies were confirmed in 15 (0?15%; 95% CI 0?09?0?24) of 10 009 people in six of the 13 provinces. The mean age of seropositive individuals was significantly younger than that of patients with reported, laboratory-confirmed, primary Middle Eastern respiratory syndrome (43?5 years [SD 17?3] vs 53?8 years [17?5]; p=0?008). Men had a higher antibody prevalence than did women (11 [0?25%] of 4341 vs two [0?05%] of 4378; p=0?028) and antibody prevalence was significantly higher in central versus coastal provinces (14 [0?26%] of 5479 vs one [0?02%] of 4529; p=0?003). Compared with the general population, seroprevalence of MERS-CoV antibodies was significantly increased by 15 times in shepherds (two [2?3%] of 87, p=0?0004) and by 23 times in slaughterhouse workers (five [3?6%] of 140; p<0?0001).
[h=4]Interpretation[/h] Seroprevalence of MERS-CoV antibodies was significantly higher in camel-exposed individuals than in the general population. By simple multiplication, a projected 44 951 (95% CI 26 971?71 922) individuals older than 15 years might be seropositive for MERS-CoV in Saudi Arabia. These individuals might be the source of infection for patients with confirmed MERS who had no previous exposure to camels.
http://www.sciencedirect.com/science/article/pii/S1473309915700903
- Marcel A M?ller, PhD[SUP]a[/SUP],
- Benjamin Meyer, MSc[SUP]a[/SUP],
- Victor M Corman, MD[SUP]a[/SUP][SUP], [/SUP][SUP]b[/SUP],
- Malak Al-Masri, BSc[SUP]f[/SUP],
- Abdulhafeez Turkestani, MD[SUP]g[/SUP],
- Daniel Ritz, MSc[SUP]a[/SUP],
- Andrea Sieberg, BSc[SUP]a[/SUP],
- Souhaib Aldabbagh, DVM[SUP]a[/SUP],
- Berend-J Bosch, PhD[SUP]h[/SUP],
- Erik Lattwein, PhD[SUP]i[/SUP],
- Raafat F Alhakeem, MD[SUP]f[/SUP],
- Abdullah M Assiri, MD[SUP]f[/SUP],
- Ali M Albarrak, MD[SUP]c[/SUP],
- Ali M Al-Shangiti, PhD[SUP]d[/SUP],
- Jaffar A Al-Tawfiq, MD[SUP]j[/SUP][SUP], [/SUP][SUP]k[/SUP],
- Paul Wikramaratna, PhD[SUP]l[/SUP],
- Abdullah A Alrabeeah, MD[SUP]e[/SUP],
- Prof Christian Drosten, MD[SUP]a[/SUP][SUP], [/SUP][SUP]b[/SUP][SUP], [/SUP][SUP], [/SUP][SUP]?[/SUP][SUP], [/SUP],
- Prof Ziad A Memish, MD[SUP]f[/SUP][SUP],[/SUP]
[h=4]Findings[/h] Between Dec 1, 2012, and Dec 1, 2013, we obtained individual serum samples from 10 009 individuals. Anti-MERS-CoV antibodies were confirmed in 15 (0?15%; 95% CI 0?09?0?24) of 10 009 people in six of the 13 provinces. The mean age of seropositive individuals was significantly younger than that of patients with reported, laboratory-confirmed, primary Middle Eastern respiratory syndrome (43?5 years [SD 17?3] vs 53?8 years [17?5]; p=0?008). Men had a higher antibody prevalence than did women (11 [0?25%] of 4341 vs two [0?05%] of 4378; p=0?028) and antibody prevalence was significantly higher in central versus coastal provinces (14 [0?26%] of 5479 vs one [0?02%] of 4529; p=0?003). Compared with the general population, seroprevalence of MERS-CoV antibodies was significantly increased by 15 times in shepherds (two [2?3%] of 87, p=0?0004) and by 23 times in slaughterhouse workers (five [3?6%] of 140; p<0?0001).
[h=4]Interpretation[/h] Seroprevalence of MERS-CoV antibodies was significantly higher in camel-exposed individuals than in the general population. By simple multiplication, a projected 44 951 (95% CI 26 971?71 922) individuals older than 15 years might be seropositive for MERS-CoV in Saudi Arabia. These individuals might be the source of infection for patients with confirmed MERS who had no previous exposure to camels.
http://www.sciencedirect.com/science/article/pii/S1473309915700903